Skip to main content
FRMSL logo

FRMSL — Investor Relations & Filings

Ticker · 4746 ISIN · TW0004746003 TW Manufacturing
Open in API
Filings indexed 1,872 across all filing types
Latest filing 2022-03-22 Regulatory Filings
Country TW Taiwan
Listing TW 4746

About FRMSL

www.formosalab.com

Formosa Laboratories, Inc. is a Contract Development and Manufacturing Organization (CDMO) specializing in the development and production of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. The company provides integrated services ranging from process development and custom synthesis to large-scale commercial manufacturing. Its core product portfolio includes UV-filters, Vitamin D derivatives, and polymers such as cholesterol and phosphate binders. Formosa Laboratories offers specialized expertise in Antibody-Drug Conjugates (ADCs) and injectable manufacturing, including cytotoxic and freeze-dried products. Maintaining high quality standards, its facilities are cGMP-compliant and have been successfully inspected by the US FDA, TFDA, EDQM, and PMDA. The company serves a global clientele, providing one-stop solutions for complex chemical synthesis, fermentation, and peptide production.

Recent filings

Filing Released Lang Actions
110年第4季大陸投資
Regulatory Filings Classification · 95% confidence The document is a detailed tabular disclosure of investment amounts and related financial data concerning investments in mainland China by a Taiwanese listed company (台耀). It includes specific financial figures, investment methods, and regulatory limits as per the Economic Ministry's Investment Commission. The document is relatively short (1291 characters) and focuses on investment details rather than a full financial report or announcement. It does not contain comprehensive financial statements or management discussion, nor is it an announcement of a report publication. The content aligns with regulatory disclosure requirements about overseas investments, which typically fall under general regulatory filings. There is no indication this is an annual or interim report, audit report, or any other specific report type. Therefore, the best classification is Regulatory Filings (RNS).
2022-03-22 Chinese
更正董事會通過110年度合併財務報告之歸屬於母公司業主 淨利
Regulatory Filings Classification · 95% confidence The document is a short announcement (951 characters) from a listed company (4746 台耀) correcting a previously reported financial figure related to the consolidated financial report for the fiscal year 110 (2021). It includes specific financial data such as net profit attributable to the parent company, revenue, gross profit, and earnings per share. The document states it is a correction of the board-approved consolidated financial report. However, the length and format indicate it is not the full annual report but rather a regulatory announcement correcting financial data. There is no indication that this is the full annual report (10-K) or an audit report. It is a regulatory filing correcting financial information previously disclosed, fitting best under Regulatory Filings (RNS).
2022-03-15 Chinese
111年03月法人說明會簡報 — 474620220314E001.pdf
Investor Presentation Classification · 95% confidence The document is titled 'Formosa Laboratories, Inc. Company Presentation' and contains detailed information about the company's operations, sales figures, business strategy, product lines, and facilities. It includes forward-looking statements, financial data such as sales and profitability metrics, and descriptions of business segments and partnerships. The content is structured as a presentation with slides and charts, focusing on financials, strategy, and market position. There is no indication that this is an official annual or quarterly report, audit report, or regulatory filing. It is not a transcript, voting result, or legal proceeding update. The document is a detailed presentation aimed at investors or stakeholders, consistent with the definition of an Investor Presentation (IP). The length (9912 characters) and content support this classification rather than a brief factsheet or announcement.
2022-03-14 Chinese
111年03月法人說明會簡報 — 474620220314M001.pdf
Investor Presentation Classification · 95% confidence The document is a detailed presentation containing operational performance data, revenue figures, business strategies, product lines, and service capabilities of 台耀化學股份有限公司 (Taiyo Chemical Co., Ltd.) for the year 2021. It includes charts, tables, and descriptions of various business segments such as raw materials, CDMO services, and injection business. The content is typical of an investor presentation focusing on financials, strategy, and market position rather than a formal annual report or regulatory filing. There is no indication that this is a full annual report (10-K), audit report, or earnings release. The presence of forward-looking statements and disclaimers further supports it being a presentation. The document length (6233 characters) and the detailed business and financial overview align with an Investor Presentation (IP).
2022-03-14 Chinese
111年03月法人說明會簡報
Investor Presentation Classification · 95% confidence The document is a listing from a public information observation station showing details about a scheduled corporate presentation event, specifically a '法人說明會' which translates to 'investor presentation' or 'analyst meeting'. It includes company code, name, date, time, location, summary of the presentation content, and links to presentation materials. There is no financial data or report attached, but rather information about the event and presentation materials. This matches the definition of an Investor Presentation (IP). The document length is short and it is not an announcement of a report publication but the presentation itself.
2022-03-14 Chinese
110年度營益分析
Interim / Quarterly Report Classification · 90% confidence The document contains financial data segmented by fiscal periods such as first quarter, half-year, third quarter, and full year, with detailed metrics like operating revenue, gross margin, operating profit margin, pre-tax profit margin, and after-tax profit margin. The presence of quarterly and annual financial figures indicates this is a financial report covering periods shorter than a full fiscal year as well as the full year. The document length is only 1073 characters, which is quite short, but it contains substantive financial data rather than just an announcement or a link to a report. Therefore, it fits the definition of an Interim / Quarterly Report (IR) rather than an Annual Report (10-K) or a Report Publication Announcement (RPA).
2022-03-11 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.